GlassScriptPhysician profile
Lee H Loftin
NPI 1063443745
$1,134.97
in general payments reported to CMS, 2019-2025
16 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $47.92 · 2021: $154 · 2022: $204 · 2023: $219 · 2024: $26.21 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.82 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $484.12 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $146.74 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $109.92 | 2021-2025 | Nucala |
| Amgen INC. | $83.97 | 2025 | Tezspire |
| Aerin Medical INC. | $50.79 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $38.10 | 2021-2023 | |
| Intersect Ent, INC. | $35.59 | 2021 | |
| Novartis Pharmaceuticals Corporation | $33.74 | 2019 | |
| Optinose US, INC. | $30.44 | 2019-2020 | |
| Convatec INC. | $26.21 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $18.35 | 2025 | Neffy |
| Smith+Nephew, INC. | $17.70 | 2025 | N/A, Intellio Link Werewolf, Smith & Nephew Insufflator 500 |
| Sanofi-Aventis U.S. LLC | $16.87 | 2021 | |
| Olympus America INC. | $15.37 | 2021 | |
| Genentech USA, INC. | $14.69 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $12.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Loftin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.